Evolving Sepsis Management: Early Recognition, Biomarkers, Therapy
Received Date: Sep 01, 2025 / Published Date: Sep 29, 2025
Abstract
Sepsis management is rapidly advancing, emphasizing early recognition and intervention. Current strategies focus on dynamic
fluid resuscitation, optimal vasopressor use, and biomarker-guided therapy. Antibiotic stewardship and host-directed approaches are
crucial. Diagnosis is improving with new criteria and tools, while fluid management and vasopressor therapy are being refined based
on dynamic monitoring. Biomarkers play a key role in diagnosis and prognosis. Special populations and long-term outcomes are
increasingly addressed. Adherence to guidelines like the Surviving Sepsis Campaign is paramount.
Citation: 脗聽Hart J (2025) Evolving Sepsis Management: Early Recognition, Biomarkers, Therapy. J Clin Infect Dis Pract 10: 323.
Copyright: 漏 2025 Jack Hart This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,聽distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Usage
- Total views: 240
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 186
- PDF downloads: 54
